Project Grant R01NS139519

Award Date 1/1/25
Completion Date 12/31/29
Dollars Obligated $676K
Federal Grant Program
93.853
Assistance Type
Project Grant
Place of Performance
Memphis, TN 38105, USA
Similar Awards
This federal Project Grant award of $897,250 from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) will support research focused on understanding the role of biomolecular condensates, such as ribonucleoprotein (RNP) granules, in governing RNA metabolism and their relationship to neurological diseases. The 8-year research program, led by St. Jude Children's Research Hospital...
This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $478,732 to Seattle Children's Hospital to characterize the cellular and molecular features of human cerebellar progenitor zones. The research leverages expertise in human cerebellar development and access to fetal tissue to conduct in vitro assays, live imaging, and...
This Project Grant award, valued at $481,250.00 and provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, aims to develop a synthetic biological system to manipulate subcellular RNAs and proteins in growth cones or synapses of subtype- and context-specific neurons. The goal is to enable unique forms of subcellular functional investigation in subtype- and...
This federal Project Grant award of $985,026 from the National Institute of Neurological Disorders and Stroke (NINDS) under CFDA 93.853 - Extramural Research Programs in the Neurosciences and Neurological Disorders, aims to investigate the roles and mechanisms of epitranscriptomic regulation in the development and function of the mammalian nervous system, as well as the pathological consequences of disrupting these processes. The research program will utilize mouse models and human induced...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $1,341,874 project grant under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) to The Regents of the University of California, San Francisco (UCSF). The grant supports research focused on elucidating the molecular mechanisms that control dendrite development, as well as studying mechanosensation and regeneration in Drosophila dendritic arborization (DA) neurons. Key...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $190,485.00 to Indiana University Indianapolis to investigate the molecular mechanisms underlying differentiation failure in NF2 mutant neuroepithelial stem cells. The goal is to identify the cellular hierarchy and dysregulated signaling pathways in these cells, as well as to...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $1,270,816 to Yale University to conduct research aimed at uncovering the gene regulatory networks that control the development and function of radial glia, the stem cells of the human brain. The research combines cerebral organoids, single-cell CRISPR screens, spatial...
The $258,342 Project Grant from the National Institutes of Health's National Institute of Neurological Disorders and Stroke will support research into the mechanisms of dendritic tiling at Stanford University. Specifically, the grant will fund two specific aims: first, to test the hypothesis that activity-dependent mechanisms result in tiling of dendrites in C. elegans using live imaging of neighboring neurons labeled with distinct fluorescent reporters; and second, to assess the impact of...
This federal Project Grant award of $1,008,977 from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, is funding research to understand human brain development and the origins of neurodevelopmental diseases. The primary focus is on studying the genomic, cellular, and behavioral features of outer radial glia (ORG) and intermediate progenitor (IP) neural progenitor cells...
This federal Project Grant award for $142,452.00 was provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The funding supports research to develop novel mRNA-based gene therapies for the treatment of diffuse midline glioma (DMG), a lethal pediatric brain tumor. The principal investigator will optimize the delivery of mRNA using lipid nanoparticles to target the...

This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $676,388 to St. Jude Children's Research Hospital Inc. to conduct research focused on understanding how polarity signaling in neuronal development links nuclear reorganization to neuronal differentiation. The award supports in vivo genetics and ex vivo mechanistic studies, along with transformative single-cell imaging technologies, to explore how specific proteins (SIAH2, PARD6A) regulate chromatin compaction and nuclear condensation during cerebellar granule neuron development. This research aims to provide a new conceptual model of neuronal differentiation processes, which could lead to new diagnostics or treatments for neurodevelopmental disorders and pediatric cancers where neuronal differentiation is compromised. The project will be conducted from January 1, 2025 through December 31, 2029.

Generated 7/15/25, 10:43 AM